Global Recombinant Human Serum Albumin(HSA) Market Growth 2025-2031
Description
The global Recombinant Human Serum Albumin(HSA) market size is predicted to grow from US$ 116 million in 2025 to US$ 216 million in 2031; it is expected to grow at a CAGR of 10.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
As the most abundant protein in human plasma, human serum albumin (HSA) is a transporter of hormones, lipids and other substances. Its main physiological function is to regulate plasma pH and maintain plasma osmotic pressure. Human serum albumin is a single-chain protein composed of 585 amino acids with a molecular weight of 66.5kDa.
Albumin can provide nitrogen and essential amino acids that are important for cell growth and help maintain osmotic pressure balance in the cell culture environment. In addition, albumin can also serve as a substrate for cell attachment, help stabilize pH, and even protect cells from stress and damage. Albumin is usually added to cell culture media at different concentrations - depending on the cell type and culture application. It can also serve as a carrier protein for hormones, vitamins and other growth factors. In addition, HSA can be used as a stabilizer and/or adjuvant in vaccines.
United States market for Recombinant Human Serum Albumin(HSA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Recombinant Human Serum Albumin(HSA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Recombinant Human Serum Albumin(HSA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Recombinant Human Serum Albumin(HSA) players cover Merck, MP Biomedicals, Proteintech, InVitria, Sino Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Serum Albumin(HSA) Industry Forecast” looks at past sales and reviews total world Recombinant Human Serum Albumin(HSA) sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Human Serum Albumin(HSA) sales for 2025 through 2031. With Recombinant Human Serum Albumin(HSA) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Serum Albumin(HSA) industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Serum Albumin(HSA) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Serum Albumin(HSA) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Serum Albumin(HSA) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Serum Albumin(HSA) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Serum Albumin(HSA).
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Serum Albumin(HSA) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Yeast Expression System
Mammalian Cell Expression System
Plant Expression System
Insect Cell Expression System
Segmentation by Application:
Biopharmaceuticals
Cell Culture & Regenerative Medicine
In Vitro Diagnostics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
MP Biomedicals
Proteintech
InVitria
Sino Biological
Reprokine
ACROBiosystems
Assay Genie
Cell Biologics
Sartorius AG
Yeasen
MedChemExpress
Abcam
Basic Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Human Serum Albumin(HSA) market?
What factors are driving Recombinant Human Serum Albumin(HSA) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Serum Albumin(HSA) market opportunities vary by end market size?
How does Recombinant Human Serum Albumin(HSA) break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
As the most abundant protein in human plasma, human serum albumin (HSA) is a transporter of hormones, lipids and other substances. Its main physiological function is to regulate plasma pH and maintain plasma osmotic pressure. Human serum albumin is a single-chain protein composed of 585 amino acids with a molecular weight of 66.5kDa.
Albumin can provide nitrogen and essential amino acids that are important for cell growth and help maintain osmotic pressure balance in the cell culture environment. In addition, albumin can also serve as a substrate for cell attachment, help stabilize pH, and even protect cells from stress and damage. Albumin is usually added to cell culture media at different concentrations - depending on the cell type and culture application. It can also serve as a carrier protein for hormones, vitamins and other growth factors. In addition, HSA can be used as a stabilizer and/or adjuvant in vaccines.
United States market for Recombinant Human Serum Albumin(HSA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Recombinant Human Serum Albumin(HSA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Recombinant Human Serum Albumin(HSA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Recombinant Human Serum Albumin(HSA) players cover Merck, MP Biomedicals, Proteintech, InVitria, Sino Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Serum Albumin(HSA) Industry Forecast” looks at past sales and reviews total world Recombinant Human Serum Albumin(HSA) sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Human Serum Albumin(HSA) sales for 2025 through 2031. With Recombinant Human Serum Albumin(HSA) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Serum Albumin(HSA) industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Serum Albumin(HSA) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Serum Albumin(HSA) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Serum Albumin(HSA) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Serum Albumin(HSA) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Serum Albumin(HSA).
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Serum Albumin(HSA) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Yeast Expression System
Mammalian Cell Expression System
Plant Expression System
Insect Cell Expression System
Segmentation by Application:
Biopharmaceuticals
Cell Culture & Regenerative Medicine
In Vitro Diagnostics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
MP Biomedicals
Proteintech
InVitria
Sino Biological
Reprokine
ACROBiosystems
Assay Genie
Cell Biologics
Sartorius AG
Yeasen
MedChemExpress
Abcam
Basic Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Human Serum Albumin(HSA) market?
What factors are driving Recombinant Human Serum Albumin(HSA) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Serum Albumin(HSA) market opportunities vary by end market size?
How does Recombinant Human Serum Albumin(HSA) break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
112 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Recombinant Human Serum Albumin(HSA) by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Recombinant Human Serum Albumin(HSA) by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
